FDA Investigator Xianghong Jing (Emily), PhD
Xianghong Jing (Emily), PhD has inspections in 4 countries as of 21 Jul 2023. Xianghong Jing (Emily), PhD has collaborated with a combinined 1587 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
4
Last Inspection Date:
21 Jul 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
Austria,
Denmark,
Switzerland,
United States of America
Co-Investigator(s):
Anissa M Cheung,
Anita Narula, PhD,
Anthony F Lorenzo,
Arsen Karapetyan,
Barbara Janine Breithaupt,
Bo Chi, PhD,
Brandon C Heitmeier,
Brian M Janelsins, PhD,
Bruce H Mccullough,
CDR Cecily Jones,
CDR Jeremy L Wally, PhD,
Chikako Torigoe, PhD,
Christian D Lynch (CDL),
Christopher Downey, PhD,
David G Eng,
Deborah Schmiel, PhD,
Dennis Cantellops Paite,
Douglas A Campbell,
Dr. Ralph M Bernstein, PhD,
Edmund F Mrak, Jr,
Ephrem Hunde, PhD,
Gene D Arcy,
George Pyramides,
Gloria E Parra,
Gwyn G Dickinson,
Haruhiko Murata,
Jacek Cieslak, PhD,
Jacqueline Mdiaz Albertini,
James D Bridges,
James I Giefer,
James L Dunnie, Jr,
Jean Lhu Primmer,
Jose Acruz Gonzalez,
Jose Alopez Rubet,
Kalavati Suvarna, PhD,
Kevin A Gonzalez,
Kevin D Kallander,
Kevin P Foley,
Larry K Austin,
Lawrence J Stringer,
Margaret M Annes,
Maria Gutierrez Lugo, PhD,
Maria Joselopez Barragan, PhD,
Melissa D Ray,
Michael A Charles,
Michael E Maselli,
Michael J Vardon,
Michael Shanks, MS,
Michelle Y Clark Stuart,
Niketa Patel,
Pankaj H Amin,
Parul M Patel,
Patricia Fhughes Troost,
Patrick L Wisor,
Patsy J Domingo,
Paul A Bonneau,
Paul D Keller,
Paul W Keller,
Penny H Mccarver,
Prabhu P Raju,
Priscilla M Pastrana,
Randa Melhem, PhD,
Rashmi Rawat, PhD,
Rebecca E Dombrowski,
Rebecca Rodriguez,
Reyes Candau Chacon, PhD,
Robert D Tollefsen,
Samina S Khan,
Santos E Camara,
Sidney B Priesmeyer,
Simone E Pitts,
Stephen D Eich,
Steven A Rubin,
Susan M Jackson,
Susant Hadman,
Thomas J Arista,
Thuy T Nguyen, LCDR,
Tina M Pawlowski,
Torrance J Slayton,
Wayne E Seifert,
Xiao Wang,
Yehualashet A Gessesse,
Zhong Li, PhD
Xianghong Jing (Emily), PhD's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| February, 2014 | FDA 483 | Seqirus Inc - Form 483, 2014-02-12 |
| December, 2021 | FDA 483 | Sandoz GmbH - Form 483, 2021-12-17 |
| July, 2016 | FDA 483 | FUJIFILM Diosynth Biotechnologies Denmark ApS - Form 483, 2016-07-08 |
| January, 2016 | FDA 483 | F. Hoffmann-La Roche AG - Form 483, 2016-01-22 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more